about
sameAs
"Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out modelRole of microglia in CNS autoimmunityIdentifying the start of multiple sclerosis injury: a serial DTI studyImpaired neurosteroid synthesis in multiple sclerosis.FLT-3 expression and function on microglia in multiple sclerosis.Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.Local assessment of myelin health in a multiple sclerosis mouse model using a 2D Fourier transform approachClusters of activated microglia in normal-appearing white matter show signs of innate immune activationInflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelinationSmall heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis.Absence of system xc- on immune cells invading the central nervous system alleviates experimental autoimmune encephalitis.Oligodendrocyte-microglia cross-talk in the central nervous system.Can we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis.Inflammation in neurodegenerative diseases--an update.A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model.AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 mice.Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitisα7 nicotinic acetylcholine receptor signaling modulates the inflammatory phenotype of fetal brain microglia: first evidence of interference by iron homeostasisLoss of corticospinal tract integrity in early MS disease stages.Saffold cardiovirus and multiple sclerosis: no evidence for an association.Innate and adaptive immune responses in neurodegeneration and repair.Lipid Order Degradation in Autoimmune Demyelination Probed by Polarized Coherent Raman Microscopy.Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.Absence of CCL2 and CCL3 Ameliorates Central Nervous System Grey Matter But Not White Matter Demyelination in the Presence of an Intact Blood-Brain Barrier.Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis.Human Endogenous Retroviruses and Their Putative Role in the Development of Autoimmune Disorders Such as Multiple Sclerosis.Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis.
P2860
Q26779366-DCF79F5C-E439-46EC-AA4C-F59C6952F523Q27003940-12725443-3BC4-45BC-872F-14BAB8009CC3Q28250952-EC6594F3-DE30-4106-85D1-B4A18617673AQ34077547-2D84C44E-EA01-4F73-828F-30080FF89DFFQ34126511-8F0411DD-7B74-4F71-A7AD-90B26E0976DAQ34324660-9128E108-BB29-440D-B942-40C2CB690F2AQ34468304-486EBCB1-8827-442A-8F69-5F32C4DF53D3Q34476372-79764104-9B33-42CF-A104-A3771784DBFDQ35025606-D1337826-1F75-4292-B7E3-5510C66FC2ABQ36138891-DE04E28E-6E88-46EC-AA12-CD55D8CB2BFAQ36147149-FD5A9286-9E9A-4680-9129-4A192DF7B9B2Q36398055-33EA8C93-3D6B-4941-80D5-6E1C7833DAAEQ36445604-E97F5570-C771-47BD-B36D-4B9F609A37C7Q36513651-858E5077-1817-4CB1-B469-9E225E338853Q36976299-D56B9CAE-363C-44E8-B746-DBBDDD5CD063Q37561684-C4982E23-B78A-41CF-A606-F0E229935B95Q37586538-092EDAC8-FD38-451F-A5F3-620D41FD9A1AQ38131845-39A27A38-430B-4D07-BDBB-0CBEA6A5E0FBQ38151732-B99029BA-D775-46F6-A335-3F23E5FF1C2DQ38170472-574287D5-49B6-4676-AFB7-63F1E3AF8208Q39458392-C7E738EF-5F72-48DF-810E-25CA2CD4D235Q39893541-04FD1830-3A8B-4CE7-B816-9D56D1111B24Q41594953-1E5EB678-EA4B-4027-A4E3-09A1182327C5Q41636775-12841DA4-BD8F-4E5F-B985-5157C738231AQ41676647-546E1BAA-6853-4160-B6E9-9520A7B6DD7FQ41684090-8821B783-3774-41BD-A4B3-6DB3DEEC10E6Q44581205-9CB6F190-8430-4725-BA31-2CC58B5B9931Q47697450-3250BFA1-8792-4560-A79E-29FE9F3A9472Q47758851-AE33BB77-801C-4212-ACF3-0B98211AA957Q48338353-9D9E7097-17ED-47D5-9A0F-0C9806492815Q50021192-2A756EBD-5D53-4748-A7B8-DEEBD10587BFQ52363776-AF62E2EE-C587-4D9D-B394-C44381FCD481Q55399614-B8A84AD6-F9AD-4419-A750-20B14D0385A3
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Preactive lesions in multiple sclerosis
@ast
Preactive lesions in multiple sclerosis
@en
Preactive lesions in multiple sclerosis
@nl
type
label
Preactive lesions in multiple sclerosis
@ast
Preactive lesions in multiple sclerosis
@en
Preactive lesions in multiple sclerosis
@nl
prefLabel
Preactive lesions in multiple sclerosis
@ast
Preactive lesions in multiple sclerosis
@en
Preactive lesions in multiple sclerosis
@nl
P3181
P1476
Preactive lesions in multiple sclerosis
@en
P2093
Paul van der Valk
Sandra Amor
P3181
P356
10.1097/WCO.0B013E32832B4C76
P407
P577
2009-05-01T00:00:00Z
2009-06-01T00:00:00Z